MedTrace Logo

Mental Health Consequences of COVID19 Infection in the French RMD Cohort

NCT04510467 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 296

Last updated 2023-01-13

No results posted yet for this study

Summary

this observational, cross-sectional, national, comparative study, including RMD patients followed in hospital centres of the FAI²R Rare Diseases Healthcare Pathway network and specialist private practitioners caring for patients suffering from inflammatory rheumatism, systemic autoimmune diseases and auto-inflammatory diseases. The objective of the study is to compare RMD patients with COVID 19 infection (cases) to RMD patients who have not had COVID 19 infection (controls) on their mental health.

Conditions

  • Covid19
  • Systemic Autoimmune Disease
  • Inflammatory Rheumatism
  • Auto Inflammatory Diseases

Sponsors & Collaborators

  • FAI²R (Auto-immune and auto-inflammatory rare diseases French network)

    collaborator UNKNOWN

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Eric Hachulla, MD,PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-20
Primary Completion
2022-05-19
Completion
2022-05-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04510467 on ClinicalTrials.gov